Penicillin G acylase market was valued at US$ 151.3 million in 2024 and is projected to hit the market valuation of US$ 251.4 million by 2033 at a CAGR of 5.8% during the forecast period 2025–2033.
U.S. durable medical equipment market was valued at US$ 80.9 billion in 2024 and is projected to hit the market valuation of US$ 137.9 billion by 2033 at a CAGR of 6.1% during the forecast period 2025–2033.
Intravenous hydration therapy market was valued at US$ 2.8 billion in 2024 and is projected to hit the market valuation of US$ 4.9 billion by 2033 at a CAGR of 6.2% during the forecast period 2025–2033.
US cell culture supplements market was valued at US$ 835.9 million in 2024 and is projected to hit the market valuation of US$ 2,491.6 million by 2033 at a CAGR of 12.9% during the forecast period 2025–2033.
Functional Service Providers (FSP) market was valued at US$ 17.9 billion in 2024 and is projected to hit the market valuation of US$ 38.56 billion by 2033 at a CAGR of 8.9% during the forecast period 2025–2033.
Breastfeeding accessories market was valued at US$ 1.9 billion in 2024 and is projected to hit the market valuation of US$ 4.2 billion by 2033 at a CAGR of 8.8% during the forecast period 2025–2033.